Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Reconciliation of net loss to net cash used in operating activities:    
Net loss $ (6,026) $ (6,470)
Stock option compensation to employees and directors 1,993 2,346
Stock options issued to consultants 50 78
Common stock issued to consultants 96
Amortization of operating lease right-of-use asset 18 25
Amortization of discount on held-to-maturity securities (79)
Change in operating assets and liabilities:    
Receivables 173 52
Prepaid expenses and other current assets 96 485
Accounts payable (241) 9
Accrued expenses (380) (360)
Operating lease liability (11) (26)
Net cash used in operating activities (4,407) (3,765)
Cash flows from investing activities:    
Disbursements to acquire short-term investments (24,929) (34,738)
Proceeds from maturities of short-term investments 29,974 35,423
Net cash provided by investing activities 5,045 685
Cash flows from financing activities:    
(Expenses) proceeds from sale of common stock in an at-the-market offering, net of offering expenses of $51 and $94, respectively (3) 3,029
Proceeds from sale of common stock pursuant to an employee stock purchase plan 4 7
Proceeds from exercise of stock options 124
Net cash provided by financing activities 1 3,160
Net increase in cash and cash equivalents 639 80
Cash and cash equivalents at beginning of period 1,271 915
Cash and cash equivalents at end of period $ 1,910 $ 995